Italy's Chiesi Group has revealed plans to spend €430 million ($464 million) on a new therapeutics manufacturing facility at ...

The field is evolving—don’t get left behind. Expand your network and join 80+ structural biologists, medicinal chemists, ...

Eli Lilly's direct-to-consumer platform LillyDirect has been expanded to include in-person and telehealth services for people ...

At JP Morgan 2025, pharmaphorum editor-in-chief Jonah Comstock sat down with Dr Michael Bauer, CEO of Quantro Therapeutics, about his company’s novel approach to gene transcription factor control.

“Differently from the US, in Europe most of the reimbursement is managed at the national level, so not at the European Union ...

Soleno Therapeutics' Vykat XR has become the first FDA-approved treatment for Prader-Willi syndrome (PWS), a rare genetic ...

The growing burden of misinformation is a complex issue that demands a direct-to-patient channel through trusted sources. By ...

The UK government is providing £2 million ($2.6 million) in funding to allow digital assessment to be added to a ...

New US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has said he intends to save $1.8 billion per year, ...

The company ended 2024 with just under $127 million in cash reserves, and nothing in its pipeline beyond the Alzheimer's ...

It has already been speculated that AstraZeneca's termination of a plan to invest £450 million in a new vaccine manufacturing ...

Character Biosciences has raised $93m in an oversubscribed Series B round to speed the clinical development of a pipeline of ...